MODD Stock Catalyst: Modular Medical Completed Clinical Study for MODD1 Pump

Sep 10, 2025 · 3:59pm ET

The study was conducted to evaluate the safety and effectiveness of the device.

Max move

+53.4%

High of day $31.80

Sparker timei

3:59pm ET

MODD · Sep 10, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Modular Medical, Inc. (Nasdaq: MODD) announced the completion of a clinical study for its MODD1 Pump. The study aimed to assess the safety and effectiveness of the device in managing diabetes.

No specific amounts or filings were disclosed in the announcement. The company did not provide any comparative data or share considerations related to the study.

As of the latest available data, Modular Medical has a free float of 52,009,000 shares and 75,850,000 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time MODD sparks.

Download Sniper App →

Catch the next MODD-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →